Is Tilray Brands, Inc. (TLRY) Undervalued?
The traditional Graham Number cannot be calculated for Tilray Brands, Inc. (TLRY) due to missing data. Consider using DCF or other valuation methods for a complete picture.
Analysis updated March 8, 2026
TLRY Key Valuation Metrics
| Metric | Value | Signal |
|---|---|---|
| Current Price | $7.21 | — |
| Graham Number | N/A | — |
| P/E Ratio | N/A | Unprofitable |
| P/B Ratio | 0.36 | ▲ Low |
| DCF Fair Value | N/A | — |
| Dividend Yield | N/A | N/A |
| 52-Week Range | $3.50 – $23.20 | Near 52-week low |
| Market Cap | N/A | Micro Cap |
| Sector | Healthcare | — |
How We Calculated TLRY's Graham Number
The Graham Number, developed by Benjamin Graham (the father of value investing), estimates a stock's maximum fair price based on its earnings and book value.
Graham Number = √(22.5 × EPS × BVPS)
For Tilray Brands, Inc. (TLRY):
- Earnings Per Share (EPS): N/A
- Book Value Per Share (BVPS): N/A
TLRY Dividend Profile
Tilray Brands, Inc. does not currently pay a dividend. This is common for growth-oriented companies that reinvest earnings back into the business to fund expansion, R&D, or acquisitions.
💡 For investors seeking income, check our Dividend Aristocrats for stocks with 25+ years of consecutive dividend increases.
TLRY Value Score: 2/10
Our proprietary value score rates Tilray Brands, Inc. a 2 out of 10, placing it in the “Overvalued / Caution” category for value investors.
Score Components
Graham Number not available
P/E not available
Trading near or below book value
DCF value not available
No dividend
Adequate financial health
Score methodology: How We Score Stocks
Stocks Similar to TLRY
These Healthcare stocks have similar valuation profiles to Tilray Brands, Inc.:
Frequently Asked Questions About TLRY
Is TLRY undervalued right now?
Based on Graham Number analysis, TLRY does not appear significantly undervalued as of March 8, 2026. The Graham Number of $N/A compared to the current price of $7.21 indicates a N/A% difference.
What is Tilray Brands, Inc.'s intrinsic value?
Using our DCF model, Tilray Brands, Inc.'s estimated intrinsic value is $N/A per share. The Graham Number suggests a fair value of $N/A.
What is the Graham Number for TLRY?
The Graham Number for TLRY is $N/A, calculated using EPS of $N/A and Book Value Per Share of $N/A. The formula is sqrt(22.5 x EPS x BVPS).
Does TLRY pay a dividend?
No, Tilray Brands, Inc. does not currently pay a dividend. The company reinvests earnings into growth.
Is TLRY a good buy right now?
Our value score rates TLRY a 2/10. The stock is in the "Overvalued / Caution" category. However, this is analysis — not financial advice. Consider your own risk tolerance, portfolio allocation, and investment timeline before making any decisions.
Start Analyzing TLRY Today
Ready to invest in Tilray Brands, Inc.? Open a free brokerage account and start trading TLRY with $0 commissions.
We may earn a commission when you open an account through our links. This does not affect our analysis or ratings.
Learn More About Value Investing
Tools
- Graham Number Calculator — Calculate the Graham Number for any stock
- DCF Calculator — Run your own discounted cash flow analysis
- Stock Screener — Filter stocks by value metrics
Related Articles
About Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resel...
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, a recommendation, or a solicitation to buy or sell any security. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions. Data sourced from Financial Modeling Prep API and may be delayed. Last updated: March 8, 2026.